Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00595764 · ClinicalTrials.gov registry record · Phase 4
Counseling for Primary Care Office-based Buprenorphine
A Phase 4 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 4
- Development phase
- 141
- Enrollment target
NCT00595764: Completed Phase 4 study, sponsored by Yale University.
NCT00595764 is a Phase 4 study that has completed, run by Yale University. The registered enrollment target is 141 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00595764, a Phase 4 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 141 participants
- Enrollment target
Study Summary
The major goal is to determine whether adding cognitive behavioral therapy to physician management will increase the efficacy of buprenorphine/naloxone treatment in an office-based primary care setting.
Primary Outcome
number of weeks of abstinence from illicit opioids, as documented by urine toxicology and self-report. Range 0 - 24.
Interventions
- BEHAVIORAL Manual-guided Physician Management (PM)
- BEHAVIORAL Physician Management (PM) combined with on-site manual-guided Cognitive Behavioral Therapy (CBT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2005-08 |
| Est. Completion | 2011-02 |
| Phase | Phase 4 |
What the finished NCT00595764 record still lists
NCT00595764 is an interventional study that assigns participants to a tested intervention. The registered 141 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 2 interventions - of which Manual-guided Physician Management (PM) is the first listed.
NCT00595764 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00595764 about?
NCT00595764 is a clinical study titled "Counseling for Primary Care Office-based Buprenorphine". The major goal is to determine whether adding cognitive behavioral therapy to physician management will increase the efficacy of buprenorphine/naloxone treatment in an office-based primary care setting.
What is the current status of trial NCT00595764?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 141 participants. The study started on 2005-08. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00595764?
The interventions under investigation include: Manual-guided Physician Management (PM) (BEHAVIORAL), Physician Management (PM) combined with on-site manual-guided Cognitive Behavioral Therapy (CBT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00595764?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00595764's enrollment target sits among peer trials
141 580th of 2000 higher than 1,420 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03042962 · 141 participants
Brain Networks in Dystonia
- NCT04378439 · 141 participants · NA
Appalachian Partnership to Reduce Disparities (Aim 2)
- NCT04775485 · 141 participants · Phase 2
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
- NCT05040360 · 141 participants · Phase 2
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia